Blogs, insights, guides and videos on India's unlisted market — all in one place.
<p>The Ministry of Municipal, Rural Affairs and Housing (MOMRA) of Saudi Arabia has enlisted OYO Rooms, a global travel-tech firm, for a comprehensive audit of accommodations. OYO will certify units adhering to MOMRA's standards, with audits initiated in January 2020 to maintain accommodation quality for the labor force.</p> <p>Private entities with 20+ employees must provide suitable accommodations. Audits are annual, and housing licenses last a year, evaluating safety, hygiene, and quality. In December 2020, MOMRA allowed OYO to expedite housing audits.</p> <p>OYO's mobile app streamlines audits, ensuring MOMRA compliance with real-time data capture, photo documentation, and instant updates. It maintains transparency and standards.</p> <p>OYO advises corrective measures for organizations with gaps, aligning with MOMRA standards. Successful audits include units for McDonald's, Al Mraie, IKK Group, Al Bawani, Pepsi Al Jomaih, Saudi Logistics Services, and Al Majal.</p> <p>OYO manages 50+ Saudi hotels, planning expansion. The partnership supports Vision 2030, aiming to make Saudi Arabia a global investment hub. Mohannad Bazerbashi, OYO Saudi Arabia's Country Head, emphasizes new hospitality standards.</p> <p>Abdulaziz Younis, Staff Housing Officer at Riyadh International Food (McDonald's), praises the app's efficiency and transparency for swift license acquisition and MOMRA compliance.</p> <p>A Knight Frank report predicts 310,000 Saudi hotel rooms by 2030 with a $110 billion investment. The segment may generate $3.02 billion by 2027, highlighting the need for streamlined approvals.</p> <p>This partnership underscores OYO's commitment to enhance Saudi Arabia's hospitality, supporting its vision to be a premier travel destination, driving economic growth through collaborations. OYO remains devoted to quality, affordable stays.</p> <p><strong>Journey of Oyo Unlisted Shares</strong> </p> <p>The Oyo Unlisted Shares exhibited notable market dynamics over the past year. In December 2022, the Oyo Unlisted Shares Price stood at Rs. 75, experiencing a subsequent increase to Rs. 90 by July 2023. However, as of December 2023, the Oyo Unlisted Shares is currently trading at Rs. 82.</p> <p>The Oyo Unlisted Shares demonstrated a growth of approximately 9.33% annually during this period.</p>
<p>Waaree Energies' recent collaboration with IRCON Renewable Power marks a pivotal moment in India's renewable energy landscape. By supplying an impressive 200 MW of DCR category solar PV modules, the partnership is set to significantly contribute to the success of IRCON Renewable Power's ambitious 500 MW grid-connected solar PV project in Pavagada, Karnataka. The strategic significance of this collaboration is underscored by the involvement of Ircon International, a key player in the public sector.</p> <p>The successful acquisition of this substantial project through a contract with the Indian Renewable Energy Development Agency Limited (IREDA) highlights the effectiveness of public-private partnerships in driving large-scale renewable energy initiatives.</p> <p>Sandesh Shetty, National Sales Head at Waaree Energies, emphasized the shared commitment to steering India's clean energy transition. This aligns with the country's broader goals of reducing carbon emissions and increasing reliance on sustainable energy sources.</p> <p>Waaree Energies' role as India's leading solar module manufacturer, with an impressive capacity of 12 GW, positions the company at the forefront of the renewable energy sector. Their dual role as an independent power producer further solidifies their influence in shaping the future of solar energy in India.</p> <p>The strategic deployment of Waaree Energies' solar PV modules in the Pavagada region not only contributes to immediate infrastructure expansion but also sets a precedent for sustainable energy adoption in similar projects nationwide. This move aligns with global efforts to transition towards cleaner energy sources and mitigates the environmental impact of traditional power generation.</p> <p>As of June 30, 2023, Waaree Energies' global footprint in over 20 countries signifies the company's commitment to advancing solar energy adoption on a global scale. This collaboration, therefore, not only reinforces Waaree Energies' industry leadership but also represents a significant step towards a more sustainable and renewable energy future for India. The ripple effect of such partnerships extends beyond business interests, playing a crucial role in shaping the trajectory of India's energy landscape.</p> <p><strong>Waaree Energies Unlisted Shares</strong> </p> <p>Waaree Energies Limited unlisted share are highly sought-after in the unlisted market. As of December 2023, the Waaree Energies Limited unlisted share price is Rs. 995. Evaluating the past year's trajectory, Waaree Energies unlisted share has demonstrated impressive performance, with the share price climbing from Rs. 900 in December 2022 to the Rs. 995 in December 2023, marking a significant growth of almost 11%.</p>
<p>After successfully concluding a substantial ₹2,320 crore one-time settlement (OTS) for Religare Finvest, the parent company, Religare Enterprises, appears to have initiated the process for an initial public offering (IPO) for its health insurance subsidiary, Care Health Insurance.</p> <p>Insiders with knowledge of the matter reveal that Care Health Insurance has extended invitations to investment bankers to present their pitches for the IPO mandate. These pitches for Care Health Insurance's IPO are anticipated to unfold over the next month. Notably, Care Health Insurance specializes in providing a range of insurance policies, including health, travel, and personal accident coverage.</p> <p>A significant portion of Care Health Insurance's financial portfolio is attributed to health-related coverage, contributing 91% to the Gross Domestic Premium Income (GDPI) and 88% to the Net Earned Premium (NEP). In a breakdown, travel insurance contributes 2.4% of GDPI and 3.4% of NEP, while personal accident (PA) coverage constitutes 6.2% of GDPI and 8.5% of NEP for Care Health Insurance.</p> <p>Sources familiar with the situation suggest that the IPO for Care Health Insurance could potentially raise between ₹1,500-2,000 crore, with an expected equity dilution ranging from 15-20%. The IPO is likely to include both secondary and primary sales of shares. Funds generated from the primary sale are earmarked for bolstering solvency and providing growth capital to the health insurer. As of Q2FY24, Care Health Insurance's solvency stood at a commendable 1.73 times, surpassing the regulatory minimum requirement of 1.5 times.</p> <p>Additionally, insiders indicate that Religare Enterprises aims to reduce its stake through the IPO, raising funds in the process. Other investors are also exploring options to divest their stake through the IPO.</p> <p>Religare issued a statement emphasizing their primary objective to create value for stakeholders and customers. They clarified that news regarding the initiation of work on Care Healthcare Insurance IPO is market speculation, adhering to their policy of not commenting on market speculation.</p> <p>In summary, the potential IPO for Care Health Insurance emerges as a pivotal financial move, following Religare Enterprises' successful OTS, signaling a strategic evolution within the company and the broader insurance sector.</p>
<p>OYO, a prominent player in the global hospitality technology landscape, has unveiled its groundbreaking 'Prime Partner Program' designed to acknowledge and incentivize its most adept hotel operators. This strategic move not only provides seasoned hotel operators with avenues for business expansion but also underscores OYO's pursuit of collaborative ventures with real estate developers to uncover and cultivate novel hotel properties across diverse regions.</p> <p>Embarking on the program's inaugural phase, OYO has forged alliances with 30 real estate partners, commencing operations in over 35 hotels strategically positioned in major cities such as Delhi, Bangalore, Hyderabad, Kolkata, Goa, Jaipur, Mumbai, Chennai, Pune, Pondicherry, and Vadodara. OYO's vision for rapid expansion involves seamlessly integrating cutting-edge technology and innovative hospitality solutions with insights derived from the real estate sector and invaluable local knowledge.</p> <p>The cornerstone of the program involves OYO striving to secure annual to long-term management contracts grounded in revenue-sharing models for 200 premium hotels nestled within Indian metros. This distinctive initiative empowers top-tier hotel operators to accrue supplementary revenue streams sans the burdensome risks associated with leasing or the overhead expenses linked to launching new hotels. As part of the package, these operators will enjoy the dedicated support of relationship managers and privileged access to OYO's expansive network boasting over 15,000 corporate accounts and more than 10,000 travel agents.</p> <p>Predominantly featuring within OYO's premium portfolio are the participating hotels, including the sophisticated offerings of Townhouse, Townhouse Oak, and Collection O. Furthermore, OYO extends a valuable proposition to property and hotel owners, presenting opportunities to lease their properties to the organization under fixed rental agreements, revenue-sharing structures, or management contracts. This not only guarantees the secure maintenance of their properties but also fosters a mutually beneficial partnership.</p> <p>Participating hotels will proudly bear the label 'Managed by OYO' on both the company's app and website, serving as a visible testament to OYO's active and hands-on involvement in their day-to-day operations. The company, committed to ensuring excellence, diligently monitors the maintenance standards and customer reviews of these establishments, paving the way for recognition and rewards for the operators who excel in delivering exceptional service.</p> <p>In essence, OYO's 'Prime Partner Program' is a transformative initiative that not only elevates the hospitality experience for guests but also establishes a symbiotic relationship between the global tech giant and its valued partners, fostering a collaborative ecosystem poised for sustained growth and success.</p>
<p>B9 Beverages, the powerhouse behind India's fourth-largest beer company, Bira 91, has orchestrated a strategic coup with the appointment of Manoj Kohli, former MD of Bharti Airtel, and Bharat Anand, Partner at Khaitan & Co., as Independent Directors. The move aims to harness their extensive global business acumen, steering Bira 91's expansion both domestically and internationally, while reinforcing corporate governance.</p> <p>In a distinguished career spanning over four decades, Manoj Kohli, credited with transforming Bharti Airtel into the world's third-largest telco, brings a wealth of experience. His leadership prowess extends beyond telecom, having been the Country Head for SoftBank India, where he played a pivotal role in guiding startups like Ola, Paytm, and WeWork. Kohli's current roles on the boards of WeWork India and Triveni Engineering, coupled with his advisory position at Deloitte India and Masters' Union, underscore his influence in diverse sectors.</p> <p>Complementing this, Bharat Anand, a luminary in corporate law and Partner at Khaitan & Co., adds legal finesse to the board. Renowned for his expertise in mergers, acquisitions, and private equity transactions in India, Anand's presence bolsters Bira 91's strategic decision-making capabilities.</p> <p>Established in 2015, B9 Beverages has evolved into a beer industry heavyweight, claiming the fourth spot in India. With a diverse beer portfolio sold in over 1000 cities across 24 countries, the company made a splash in 2023 by venturing into the Beyond Beer category with Hill Station Ciders and Grizly Seltzers. Bira 91's innovation extends to its taprooms in Bengaluru and Delhi-NCR, where a new beer is introduced weekly. The recent acquisition of The Beer Café further solidifies its presence in the pub scene.</p> <p>Backing this ambitious enterprise are key investors such as Kirin Holdings, MUFG Bank, Sofina of Belgium, and Peak XV Partners. This stellar lineup positions Bira 91 for continued success and innovation in the dynamic beverage market.</p> <p>The strategic appointments of Kohli and Anand underscore Bira 91's commitment to robust governance and strategic growth. As the company diversifies into new beverage categories, the seasoned leadership is poised to guide it through a new phase of global expansion and innovation, presenting an intriguing prospect for investors and enthusiasts alike.</p> <p> <strong>A look at Bira91 Unlisted Shares</strong></p> <p>As of November 2023, the Bira91 unlisted share price stands at Rs. 750. Over the past month, there has been a notable 21% decrease in its share value. Analysis of the historical performance reveals that in the preceding three months, the share price hovered around Rs. 600, subsequently demonstrating an upward trajectory.</p>
<p><strong>OYO Plans to Expand Holiday Home Portfolio in Dubai,ing to Digital Nomads</strong></p> <p>In response to a rising demand for flexible-term accommodations from digital nomads, Indian hospitality chain OYO has set its sights on adding 500 holiday homes to its portfolio in Dubai by 2024. This strategic move aims to provide comfortable and well-equipped spaces for the growing community of digital nomads in need of temporary living arrangements.<br /><br /><strong>Prime Destinations and Premium Offerings </strong></p> <p>OYO's expansion plans encompass some of Dubai's most sought-after locations, including Business Bay, Jumeirah Village Circle, Arjaan, Downtown, and Dubai Marina. In particular, premium apartments with stunning views of prominent landmarks like the iconic Burj Khalifa will be made available. These holiday homes will be furnished with utmost care and attention, offering fully equipped bedrooms and living areas, well-appointed kitchens, large-screen TVs, high-speed wifi connectivity, and convenient parking facilities.</p> <p><strong>Unified Tourist Visa Fuels Short-Term Rental Demand </strong></p> <p>The timing of OYO's portfolio growth in Dubai coincides with the news of the GCC member states' agreement to implement a unified tourist visa. This Schengen-style visa designates the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar as a single entity when it comes to tourist visa requirements. Previously, travelers from non-member countries had to secure separate visas for each state they wished to visit within the GCC. Now, with this unified visa in place, tourists and residents alike can enjoy longer stays and seamlessly explore the region, stimulating economic growth and creating numerous job opportunities in the tourism and hospitality sectors.</p> <p><strong>Ambitious Goals for GCC Tourism</strong> </p> <p>The GCC has set an ambitious target of attracting 128.7 million visitors by the year 2030. Among the GCC countries, the UAE stands as a prime destination, boasting 399 tourist sites out of a total of 837 in the region. As the number of tourist spots in the UAE continues to rise exponentially, it is expected to draw even more travelers from abroad in the coming years.</p> <p><strong>OYO UAE's Ambition</strong> </p> <p>Karan Ashok, the Head of OYO UAE, expressed excitement over the hospitality chain's ambitious plans to expand their holiday home offerings in Dubai. Ashok emphasized the importance of catering to the unique lifestyle and work preferences of digital nomads, ensuring they have access to comfortable and well-equipped spaces.</p> <p><strong>OYO's Financial Endeavors </strong></p> <p>In pursuit of its goals, OYO is actively seeking to raise $250 million from investors. Their initial plan included going public through an IPO during the Indian festival of Diwali on November 12th. However, the IPO process has faced multiple delays since the initial filing in 2021. With a current valuation target set between $3 billion and $5 billion, OYO remains steadfast in its pursuit of growth and expansion.<br /><br /><strong>History of OYO Unlisted Shares</strong><br /><br />OYO is a hospitality chain that originated in India and has expanded globally. Founded in 2013 by Ritesh Agarwal, OYO revolutionized the budget accommodation sector by providing standardized and affordable hotel rooms. The company started as OYO Rooms and has since diversified its services.</p> <p>OYO's business model involves partnering with budget hotels, guesthouses, and property owners, rebranding and renovating the establishments to meet specific quality standards. Through its online platform and mobile app, OYO offers users a seamless booking experience for a range of accommodations, from budget to mid-range options.</p> <p>The company quickly gained popularity due to its focus on providing clean, comfortable rooms with standardized amenities at reasonable prices. OYO's rapid expansion led it to operate in multiple countries, including India, China, the United States, Europe, and various other locations worldwide.</p> <p><strong>OYO Unlisted Shares Journey in Unlisted Space </strong></p> <p>Talking about OYO unlisted shares, they are some of the most popular unlisted shares. In November 2022, OYO unlisted share price was Rs. 75 which increased to Rs. 82 in November 2023, an impressive growth of almost 10% at the severe economic conditions. </p> <p><strong>A Look at OYO unlisted shares 2022-23 Annual Reports </strong></p> <p>1. OYO unlisted shares reported a 14% increase in Total Income for FY23, reaching ₹5602 crore from ₹4905 crore.<br /><br />2. The company significantly reduced its Net Losses by 34%.<br /><br />3. Adjusted EBITDA losses also saw a remarkable decrease of 68%, narrowing to ₹-374 crore from ₹-1160 crore in the previous year.<br /><br />4. The company has launched 10 Palette resorts in cities including Jaipur, Hyderabad, and Mumbai, with plans to add 40 more Pallete Resort to its portfolio by Q2 FY 2024.</p> <p>In summary, OYO's expansion plans entail adding 500 holiday homes to their portfolio in Dubai by 2024. By strategically targeting prime locations and offering premium accommodations, OYO aims to meet the growing demand for flexible-term stays among digital nomads. Furthermore, the implementation of a unified tourist visa across GCC member states is expected to boost short-term rental demand and stimulate the regional tourism industry. As OYO continues to seek financial backing to fuel its growth, the company demonstrates its commitment to providing comfortable and well-equipped spaces that cater to the unique lifestyle and work preferences of its guests.</p>
<p>PharmEasy, a major healthtech player, recently appointed Yatharth Bhargova as the new Group CFO of its parent company, API Holdings. He took over in September, bringing eight years of experience from OLX. This move follows the departure of former CFO CV Ram in October 2022.</p> <p>Before Bhargova, Abhinav Jain and Milind Pattarkine managed group activities. Abhinav, with nearly seven years at PharmEasy, stepped down in October. Yatharth Bhargova then became the new full-time Group CFO.</p> <p>This strategic move is crucial as PharmEasy works to settle its debt with Goldman Sachs after successfully raising INR 3500 Cr from Investors via Right issue at INR 4.85 per share. After breaching loan covenant terms earlier this year, the startup has now raised equity. The debt stemmed from acquiring Thyrocare in 2021.</p> <p>PharmEasy withdrew its IPO in 2022 and sought capital actively. In July, a rights issue raised funds, with strong support from shareholders. The goal was to reduce the debt owed to Goldman Sachs. Key investors committed to investing, including Temasek Holdings, CDPQ, LGT, ADQ, and Ranjan Pai of Manipal Health Enterprises.</p> <p>Founded in 2015, PharmEasy operates in online medicine sales and diagnostics. It raised $1 Bn with backers like B Capital, Temasek, Eight Roads Ventures, Prosus, and Bessemer Venture Partners.</p> <p><strong>Pharmeasy in Unlisted Space </strong></p> <p>Talking about Pharmeasy unlisted shares, they aren't performing well. In the unlisted space, Pharmeasy unlisted shares have been hot shares but looking at the past one year journey of Pharmeasy unlisted shares price, they are continuously falling. The Pharmeasy unlisted shares price dropped 90% from its peak. High supplies of Pharmeasy unlisted shares are pushing the price down. In Feb 2022, the share price was trading around INR 65-70 which is now trading around INR 10-12.</p>
<p>In the financial year 2023, Le Travenues Technology, the dynamic force propelling ixigo, orchestrated a financial marvel. The company not only achieved a consolidated net profit of Rs 23.4 crore but also executed a remarkable turnaround from the Rs 21.1 crore net loss in FY22 and a modest profit of Rs 7.5 crore in FY21. Renowned for pioneering travel aggregation services, ixigo flourishes on diverse revenue streams, including the sale of travel services such as rail, airline, and bus tickets, alongside a substantial influx from advertising.</p> <p>Ixigo's financial narrative reached a pivotal juncture in FY23. Domestic revenue witnessed an impressive surge, escalating from Rs 369.3 crore to a substantial Rs 487.9 crore. Simultaneously, export revenue services experienced robust growth of nearly 30 per cent, reaching Rs 13.3 crore. Factoring in interest income and other non-operating avenues, ixigo's overall revenue for FY23 culminated at an impressive Rs 517.6 crore, marking a significant leap from the Rs 384.9 crore in the preceding fiscal year. The platform proudly boasts a user base exceeding 66 million monthly active users across ixigo, ConfirmTkt, and AbhiBus.</p> <p>However, this financial triumph was not without challenges. FY23 witnessed a proportional increase in ixigo's total expenses, surging to Rs 484.3 crore from Rs 402.5 crore in the previous fiscal year. The lion's share of these expenses was attributed to employee costs, with employee benefit expenses escalating to Rs 126.3 crore, including a substantial Rs 102.6 crore dedicated to salaries and wages. Advertising and promotional expenses also experienced a notable uptick, reaching Rs 93.1 crore.</p> <p>Beyond fiscal accomplishments, ixigo's strategic vision extends to the future. The company aims for a robust 40 per cent revenue growth in FY24, with aspirations to elevate its business scale to Rs 700 crore. Despite securing SEBI's approval for a substantial Rs 1,600 crore IPO in December 2021, the startup strategically deferred its listing plan, citing market conditions as a determining factor. This strategic move reflects ixigo's agility in navigating the dynamic landscape of the business world.</p> <p>Adding to its narrative, ixigo has a rich history as a trailblazer in the traveltech industry, constantly innovating to meet evolving consumer needs. As an unlisted entity, insights from the unlisted market reveal a growing interest in Ixigo unlisted shares, reflecting investor confidence in the company's potential. This positive sentiment aligns with ixigo's strategic decision to postpone its IPO, indicating a prudent approach to market dynamics. The unlisted market suggests a keen anticipation for the company's future endeavors and underscores the value investors see in ixigo's innovative contributions to the travel sector.</p> <p><br />In the unlisted market, Ixigo unlisted shares have emerged as highly sought-after, reflecting a notable investor interest. As of November 2023, the prevailing Ixigo unlisted share price stands at approximately Rs. 98-99. Comparatively, the Ixigo unlisted share price in January 2023 was Rs. 80, indicating a commendable growth of nearly 25% over this period. This upward trajectory in the Ixigo unlisted share price underscores a positive market sentiment and affirms the company's standing.</p> <p>The robust performance of Ixigo unlisted shares is indicative of the market's confidence in the company's prospects. As this positive trajectory continues, there is a palpable expectation that the Ixigo unlisted share price will witness further appreciation in the foreseeable future. </p> <p>Founded in 2007 by Aloke Bajpai and Rajnish Kumar, ixigo has carved a significant niche in the travel technology sector. With a mission to simplify travel planning, the company launched its flagship website, ixigo.com, offering a user-friendly interface for comparing and booking various travel services. Recognizing the shift towards mobile usage, ixigo expanded its reach by introducing a mobile app in 2011, providing users with on-the-go access to seamless travel planning and booking.</p> <p>Ixigo's evolution includes strategic acquisitions, such as the 2012 purchase of Tushky, enhancing its offerings with activity discovery and booking services. The company's expansion continued with the inclusion of bus bookings, diversifying its portfolio of travel services.</p> <p>Throughout its journey, ixigo has been at the forefront of technological innovation. Features like fare predictions, real-time train running status, and personalized recommendations powered by artificial intelligence have been introduced, enhancing the overall user experience.</p>
<p>In the rapidly evolving landscape of India's e-pharmacy sector, 1mg, a Tata Digital-owned entity, has emerged as the undisputed leader, surpassing its competitor PharmEasy in gross merchandise value (GMV). Recent data from Redseer highlights 1mg's impressive climb to a 31% market share as of September 2023, marking a substantial increase from its 19% share in October 2022. In contrast, PharmEasy has experienced a significant decline, slipping from approximately 33% to 15% during the same period. It may impact the Pharmeasy unlisted shares price. Pharmeasy unlisted shares are already on the downfall. This news may fuel up the speed. Pharmeasy unlisted shares are one of the most popular shares in the unlisted space. </p> <p>This shift in market dynamics can be attributed to strategic maneuvers and a concerted effort towards profitability by industry leaders. PharmEasy, in particular, implemented stringent measures, including restrictions on marketing expenditures, as part of an extensive restructuring over the past year. This decisive move has undoubtedly impacted its market share, with a visible drop from 29% in January to 20% in May. In stark contrast, 1mg's market share has steadily risen from approximately 21% to 27% during this period.</p> <p>A prominent industry insider noted, "PharmEasy's cost-cutting measures, especially in incentivizing deliveries, have inevitably impacted its market share. While Flipkart, Apollo, and Netmeds have maintained their positions, 1mg has emerged as the frontrunner, demonstrating agility and strategic prowess."</p> <p>Beyond the realm of medication sales, a noticeable industry-wide trend suggests a general reduction in aggressive discounting across e-pharmacy platforms. This strategic shift extends to include the diagnostics business, with companies like PharmEasy and 1mg curbing discounting in their diagnostics services, contributing to a stabilization of the market.</p> <p>PharmEasy's steadfast focus on profitable growth appears to be yielding positive outcomes. The company reported a cumulative Ebitda profit of Rs 60 crore during the first six months of the current financial year, following the successful closure of its Rs 3,500-crore rights issue. This influx of funds positions PharmEasy to efficiently clear pending debts and continue its upward trajectory. On the other hand, Tata 1mg reported a remarkable 160% surge in operating revenue for the fiscal year 2022-23, reaching an impressive Rs 1,627 crore.</p> <p>The dynamics within the e-pharmacy sector unfold against the backdrop of heightened scrutiny by policymakers. In February, the Central Drugs Standard Control Organisation issued show-cause notices to several online pharmacy firms, including Tata 1mg, PharmEasy, Flipkart Health+, and Netmeds, citing potential violations of existing rules. While the companies have steadfastly asserted their role as online platforms connecting users with licensed pharmacies, the government remains vigilant, responding to concerns from offline chemists about online medicine delivery platforms.</p> <p>The heightened competition between 1mg and PharmEasy is indicative of a dynamic industry, where adaptability, strategic planning, and adherence to evolving consumer needs are paramount. The shift towards profitability and a focus on sustainable growth underscore the maturation of the e-pharmacy sector, laying the foundation for a robust and resilient future. As these industry leaders navigate challenges and opportunities, the entire sector is poised for continued growth, with consumers benefiting from a more stable and competitive e-pharmacy landscape.</p> <p>Adding a broader perspective, it's worth noting that the e-pharmacy sector's growth is not just a reflection of market share battles but also a response to evolving consumer preferences. The convenience of doorstep delivery, coupled with an increased focus on digital health, has become increasingly significant, especially in the wake of global events impacting traditional retail patterns.</p> <p>Moreover, the ongoing digitization of healthcare services, including telemedicine and digital prescriptions, is playing a pivotal role in shaping the e-pharmacy landscape. This transition signifies a broader shift towards a more integrated and technologically advanced healthcare ecosystem.</p> <p>Talking about Pharmeasy unlisted shares, they aren't performing well. In the unlisted space, Pharmeasy unlisted shares have been hot shares but looking at the past one year journey of Pharmeasy unlisted shares price, they are continuously falling. The Pharmeasy unlisted shares price dropped 90% from its peak. High supplies of Pharmeasy unlisted shares are pushing the price down. In Feb 2022, the share price was trading around Rs. 65-70 which is now trading around Rs. 10-12.</p> <p><br />In conclusion, the narrative of 1mg surpassing Pharmeasy not only explores market share dynamics but also delves into the financial struggles faced by Pharmeasy, particularly in the unlisted shares market. The continuous fall in Pharmeasy unlisted shares price, dropping by 90% from its peak, underscores the challenges posed by high supplies of Pharmeasy unlisted shares. This financial struggle adds an additional layer to the evolving strategies and resilience of industry leaders in the e-pharmacy sector. As the sector grapples with regulatory challenges and commits to sustainable growth, the future presents both challenges and exciting possibilities for industry players and the broader healthcare landscape.</p>
<p>In the latest financial report for the Q2FY24, the company has demonstrated remarkable progress, although not without its challenges. NSE continues to be the world’s largest derivatives exchange for the 4th consecutive year. Let's delve into the key figures that define the performance: <br /><br /><strong>1. Total Revenue:</strong> The total revenue has surged to an impressive Rs. 4,023 crores, marking a significant year-on-year increase of 28% from the previous year's Rs. 3,149 crores. This substantial growth in revenue underscores the Company's commitment to expanding its market presence. <br /><br /><strong>2. Operating Revenue:</strong> The Company has achieved an operating revenue of Rs. 3,652 crores, representing a 24% y-o-y increase from the previous year's Rs. 2,937 crores. <br /><br /><strong>3. Efficiency:</strong> Notably, a substantial 91% of the total revenue is attributed to operating activities, reflecting the efficiency of the core business operations. <br /><br /><strong>4. Total Expenses:</strong> While the Company's revenue has seen substantial growth, total expenses have also surged, increasing by a significant 145% from the previous year, reaching Rs. 1,420 crores, compared to Rs. 578 crores in the previous year. <br /><br /><strong>5. Cash Expenses:</strong> A significant portion of the expenses, amounting to Rs. 1,313 crores, was allocated to cash expenses, as compared to Rs. 482 crores in the previous year. <br /><br /><strong>6. Drivers of Expense:</strong> The increase in total expenses is primarily attributed to two key factors: a substantial contribution of Rs. 560 crores to the Core SGF maintained by NCL and regulatory fees amounting to Rs. 137 crores. <br /><br /><strong>7. Operating EBITDA:</strong> The operating EBITDA reflects the company's ability to generate earnings before interest, taxes, depreciation, and amortization: <strong>(i)</strong> Without Core SGF, it stands at 79% amounting to Rs. 2,899 crores, compared to 84% at Rs. 2,455 crores in the previous year. <strong>(ii)</strong> With Core SGF, it's at 64%, amounting to Rs. 2,339 crores, compared to 84% at Rs. 2,455 crores in the previous year. <br /><br /><strong>8. Associates' Contribution :</strong> The associates have contributed Rs. 26 crores to the profits, showing an increase from Rs. 19 crores in the previous year. <br /><br /><strong>9. Discontinued Operations:</strong> A net negative effect of Rs. 13 crores was observed due to discontinued operations, net of taxes. <br /><br /><strong>10. Profit After Tax:</strong> The profit after tax stands at 50%, amounting to Rs. 1,999 crores, compared to 56% at Rs. 1,774 crores in the previous year. <br /><br /><a href="https://unlistedzone.com/shares/nse-india-limited-unlisted-shares">https://unlistedzone.com/shares/nse-india-limited-unlisted-shares</a>.</p> <p> </p>
<h3 class="p1"><strong>Kurl-On Enterprise Shareholders:</strong></h3> <p class="p2">Recently, shareholders were notified via email about a buyback offer for the remaining 5.34% of KEL shares at INR 588.20 per share, which matches the rate at which Sheela Foam acquired its stake. It's important to note, however, that last year KEL's acquisition of stakes from Motilal Oswal PE Fund valued the company at approximately INR 3200 crore, or INR 870 per share. Given this context, the current buyback offer at INR 588.20 per share raises significant questions about the fairness of the valuation, potentially suggesting an undervaluation by the management.</p> <h3 class="p3"><strong>Should Investors Participate in the Buyback?</strong></h3> <p class="p2">- <strong>Hold</strong>: If investors have the holding capacity, it might be advantageous to hold the shares. The rationale behind this is that Sheela Foam’s acquisition could potentially boost Kurl-On Enterprise's operational efficiency, thereby potentially increasing revenue and net profit. This, in turn, could enhance the company’s future valuation.</p> <p>- <strong>Sell</strong>: For those facing liquidity issues, participating in the buyback could be a feasible option. Howver, the offer comes at a discount to last year value.</p> <p class="p4">For those who decide to sell, the process involves sending a request letter to the company via email.</p> <h3 class="p1"><strong>Kurl-ON Limited Shareholders:</strong></h3> <p class="p2">Having sold its 94.66% stake in Kurl-On Enterprise for INR 2035 Cr, Kurl-ON Limited now faces the significant question of how to allocate this capital.</p> <h3 class="p3"><strong>What Are the Expectations?</strong></h3> <p class="p2">- <strong>Capital Allocation</strong>: Shareholders would be keen to know if this capital will be used for debt repayment, strategic investments, or possibly returned to shareholders in some form.</p> <p>- <strong>Dividend or Share Buybacks</strong>: A special dividend or a share buyback program could be an immediate way to benefit shareholders. <br /><br />- <strong>Strategic Focus:</strong> With the major stake now sold, what will be the company’s new strategic direction? Will it diversify or double down on existing operations?</p> <h3 class="p3"><strong>Hypothetical Special Dividend Scenario:</strong></h3> <p class="p2">If we assume that Kurl-ON Limited decides to distribute the entire INR 2035 Cr as a special dividend, we can calculate the per-share dividend. Given that Kurl-ON Limited has 1.488 Cr total outstanding shares, the special dividend would amount to approximately INR 1367 per share.</p> <p><strong>However, Before we give the above fair value to Kurlon Ltd share out of sale proceeds we have to keep in mind the following, <br /><br /></strong> 1. Recently, KL acquired a 10.06% stake in KEL, purchasing it from Motilal PE Fund for a consideration of INR 325 crore. Notably, KL did not have sufficient liquid funds on its books to complete the transaction, indicating that the capital was likely borrowed. At the time of this acquisition, Motilal PE Fund's valuation for KEL stood at approximately INR 3200 crore. <br /><br />2. And, when KL has purchased the KEL shares the book value was around INR 40 Cr and today the value is INR 2035 Cr. So, they need to pay LTCG. Overall, we can say 30-35% from INR 2035 Cr will go for Debt repayment and Taxes. So, per share value would be INR 880-900 per share.</p> <p class="p2">In summary, the next moves from the management will be critical and highly anticipated by Kurl-ON Limited shareholders. It remains a compelling situation worth monitoring closely.</p>
Indicative prices, company research and your enquiries — in your pocket. Get price notes on the names you follow and reach our team from anywhere.
